Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study.

Walewski J, Paszkiewicz-Kozik E, Borsaru G, Hellmann A, Janikova A, Warszewska A, Mais A, Ammendola A, Herz T, Krauss B, Henning SW.

Leuk Lymphoma. 2018 Aug 30:1-10. doi: 10.1080/10428194.2018.1492122. [Epub ahead of print]

PMID:
30160566
2.

Assessment of efficacy and safety of the herbal medicinal product BNO 1016 in chronic rhinosinusitis.

Palm J, Steiner I, Abramov-Sommariva D, Ammendola A, Mitzenheim S, Steindl H, Wonnemann M, Bachert C.

Rhinology. 2017 Jun 1;55(2):142-151. doi: 10.4193/Rhin16.103.

PMID:
28214913
3.

Apis mellifera ligustica, Spinola 1806 as bioindicator for detecting environmental contamination: a preliminary study of heavy metal pollution in Trieste, Italy.

Giglio A, Ammendola A, Battistella S, Naccarato A, Pallavicini A, Simeon E, Tagarelli A, Giulianini PG.

Environ Sci Pollut Res Int. 2017 Jan;24(1):659-665. doi: 10.1007/s11356-016-7862-z. Epub 2016 Oct 15.

PMID:
27744589
4.

Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study.

Bitzer M, Horger M, Giannini EG, Ganten TM, Wörns MA, Siveke JT, Dollinger MM, Gerken G, Scheulen ME, Wege H, Zagonel V, Cillo U, Trevisani F, Santoro A, Montesarchio V, Malek NP, Holzapfel J, Herz T, Ammendola AS, Pegoraro S, Hauns B, Mais A, Lauer UM, Henning SW, Hentsch B.

J Hepatol. 2016 Aug;65(2):280-8. doi: 10.1016/j.jhep.2016.02.043. Epub 2016 Mar 4.

PMID:
26952006
5.

Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.

Herrlinger KR, Diculescu M, Fellermann K, Hartmann H, Howaldt S, Nikolov R, Petrov A, Reindl W, Otte JM, Stoynov S, Strauch U, Sturm A, Voiosu R, Ammendola A, Dietrich B, Hentsch B, Stange EF.

J Crohns Colitis. 2013 Sep;7(8):636-43. doi: 10.1016/j.crohns.2012.09.016. Epub 2012 Oct 16.

PMID:
23078909
6.

Vidofludimus inhibits colonic interleukin-17 and improves hapten-induced colitis in rats by a unique dual mode of action.

Fitzpatrick LR, Small JS, Doblhofer R, Ammendola A.

J Pharmacol Exp Ther. 2012 Sep;342(3):850-60. doi: 10.1124/jpet.112.192203. Epub 2012 Jun 12.

PMID:
22691298
7.

Immunosuppression with 4SC-101, a novel inhibitor of dihydroorotate dehydrogenase, in a rat model of renal transplantation.

Rusai K, Schmaderer C, Baumann M, Chmielewski S, Prókai A, Kis E, Szabó AJ, Leban J, Doblhofer R, Ammendola A, Lutz J, Heemann U.

Transplantation. 2012 Jun 15;93(11):1101-7. doi: 10.1097/TP.0b013e31824fd861.

PMID:
22609757
8.

Thienopyrimidines as β3-adrenoceptor agonists: hit-to-lead optimization.

Tasler S, Baumgartner R, Ammendola A, Schachtner J, Wieber T, Blisse M, Rath S, Zaja M, Klahn P, Quotschalla U, Ney P.

Bioorg Med Chem Lett. 2010 Oct 15;20(20):6108-15. doi: 10.1016/j.bmcl.2010.08.039. Epub 2010 Aug 12.

PMID:
20833036
9.

A vHTS approach for the identification of beta-adrenoceptor ligands.

Tasler S, Baumgartner R, Aschenbrenner A, Ammendola A, Wolf K, Wieber T, Schachtner J, Blisse M, Quotschalla U, Ney P.

Bioorg Med Chem Lett. 2010 Jun 1;20(11):3399-404. doi: 10.1016/j.bmcl.2010.04.009. Epub 2010 Apr 9.

PMID:
20434333
10.

4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr mice.

Kulkarni OP, Sayyed SG, Kantner C, Ryu M, Schnurr M, Sárdy M, Leban J, Jankowsky R, Ammendola A, Doblhofer R, Anders HJ.

Am J Pathol. 2010 Jun;176(6):2840-7. doi: 10.2353/ajpath.2010.091227. Epub 2010 Apr 22.

11.

4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease.

Fitzpatrick LR, Deml L, Hofmann C, Small JS, Groeppel M, Hamm S, Lemstra S, Leban J, Ammendola A.

Inflamm Bowel Dis. 2010 Oct;16(10):1763-77. doi: 10.1002/ibd.21264.

PMID:
20310011
12.

The peptide-semicarbazone S-2209, a representative of a new class of proteasome inhibitors, induces apoptosis and cell growth arrest in multiple myeloma cells.

Baumann P, Müller K, Mandl-Weber S, Leban J, Doblhofer R, Ammendola A, Baumgartner R, Oduncu F, Schmidmaier R.

Br J Haematol. 2009 Mar;144(6):875-86. doi: 10.1111/j.1365-2141.2008.07570.x. Epub 2009 Jan 16.

PMID:
19170678
13.

Hirayama disease: three cases assessed by F wave, somatosensory and motor evoked potentials and magnetic resonance imaging not supporting flexion myelopathy.

Ammendola A, Gallo A, Iannaccone T, Tedeschi G.

Neurol Sci. 2008 Oct;29(5):303-11. doi: 10.1007/s10072-008-0987-1. Epub 2008 Oct 21.

PMID:
18941932
14.

Clinical and electrodiagnostic follow-up of an adolescent poisoned with thallium.

Ammendola A, Ammendola E, Argenzio F, Tedeschi G.

Neurol Sci. 2007 Aug;28(4):205-8. Epub 2007 Aug 10.

PMID:
17690853
15.

Autonomic neuropathy in mixed cryoglobulinemia.

Ammendola A, Sampaolo S, Migliaresi S, Ambrosone L, Ammendola E, Ciccone G, Di Iorio G.

J Neurol. 2007 Feb;254(2):215-9. Epub 2007 Mar 2.

PMID:
17334955
16.

A multiparametric brain and cord MR imaging study of a patient with Hirayama disease.

Gallo A, Rocca MA, Tortorella P, Ammendola A, Tedeschi G, Filippi M.

AJNR Am J Neuroradiol. 2006 Nov-Dec;27(10):2115-7.

17.

Utility of multimodal evoked potentials study in neurofibromatosis type 1 of childhood.

Ammendola A, Ciccone G, Ammendola E.

Pediatr Neurol. 2006 Apr;34(4):276-80.

PMID:
16638501
18.

Computer-aided design of agents that inhibit the cep quorum-sensing system of Burkholderia cenocepacia.

Riedel K, Köthe M, Kramer B, Saeb W, Gotschlich A, Ammendola A, Eberl L.

Antimicrob Agents Chemother. 2006 Jan;50(1):318-23.

19.

Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study.

Ammendola A, Sampaolo S, Ambrosone L, Ammendola E, Ciccone G, Migliaresi S, Di Iorio G.

Muscle Nerve. 2005 Mar;31(3):382-5.

PMID:
15515001
20.

Charcot-Marie-Tooth disease with giant axons: a clinicopathological and genetic entity.

Lus G, Nelis E, Jordanova A, Löfgren A, Cavallaro T, Ammendola A, Melone MA, Rizzuto N, Timmerman V, Cotrufo R, De Jonghe P.

Neurology. 2003 Oct 14;61(7):988-90.

PMID:
14557576
21.

[Peripheral nervous system involvement in HCV-related mixed cryoglobulinemia]

Migliaresi S, Di Iorio G, Ammendola A, Ambrosone L, Sanges G, Ugolini G, Sampaolo S, Bravaccio F, Tirri G.

Reumatismo. 2001;53(1):26-32. Italian.

22.

Peripheral neuropathy in chronic alcoholism: a retrospective cross-sectional study in 76 subjects.

Ammendola A, Tata MR, Aurilio C, Ciccone G, Gemini D, Ammendola E, Ugolini G, Argenzio F.

Alcohol Alcohol. 2001 May-Jun;36(3):271-5.

PMID:
11373267
23.

Molecular determinants of the interaction between the inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate (IRAG) and cGMP kinase Ibeta.

Ammendola A, Geiselhöringer A, Hofmann F, Schlossmann J.

J Biol Chem. 2001 Jun 29;276(26):24153-9. Epub 2001 Apr 17.

24.

A new de novo mutation of the connexin-32 gene in a patient with X-linked Charcot-Marie-Tooth type 1 disease.

Di Iorio G, Cappa V, Ciccodicola A, Sampaolo S, Ammendola A, Sanges G, Giugliano R, D'Urso M.

Neurol Sci. 2000 Apr;21(2):109-12.

PMID:
10938190
25.

Gender and peripheral neuropathy in chronic alcoholism: a clinical-electroneurographic study.

Ammendola A, Gemini D, Iannaccone S, Argenzio F, Ciccone G, Ammendola E, Serio L, Ugolini G, Bravaccio F.

Alcohol Alcohol. 2000 Jul-Aug;35(4):368-71.

PMID:
10906002
26.

Inactivation of gltB abolishes expression of the assimilatory nitrate reductase gene (nasB) in Pseudomonas putida KT2442.

Eberl L, Ammendola A, Rothballer MH, Givskov M, Sternberg C, Kilstrup M, Schleifer KH, Molin S.

J Bacteriol. 2000 Jun;182(12):3368-76.

27.

Rising behind NO: cGMP-dependent protein kinases.

Hofmann F, Ammendola A, Schlossmann J.

J Cell Sci. 2000 May;113 ( Pt 10):1671-6. Review.

28.

Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta.

Schlossmann J, Ammendola A, Ashman K, Zong X, Huber A, Neubauer G, Wang GX, Allescher HD, Korth M, Wilm M, Hofmann F, Ruth P.

Nature. 2000 Mar 9;404(6774):197-201.

PMID:
10724174
29.

Monitoring the conjugal transfer of plasmid RP4 in activated sludge and in situ identification of the transconjugants.

Geisenberger O, Ammendola A, Christensen BB, Molin S, Schleifer KH, Eberl L.

FEMS Microbiol Lett. 1999 May 1;174(1):9-17.

30.

Serratia liquefaciens swarm cells exhibit enhanced resistance to predation by Tetrahymena sp.

Ammendola A, Geisenberger O, Andersen JB, Givskov M, Schleifer KH, Eberl L.

FEMS Microbiol Lett. 1998 Jul 1;164(1):69-75.

31.

Saccadic eye movements analysis in the early diagnosis of myasthenia gravis.

Tedeschi G, Di Costanzo A, Allocca S, Toriello A, Ammendola A, Quattrone A, Bonavita V.

Ital J Neurol Sci. 1991 Aug;12(4):389-95.

PMID:
1791133
32.

Carpal tunnel syndrome: a clinical electrophysiological study of 84 cases.

Bravaccio F, Trabucco M, Ammendola A, Cantore R.

Neurophysiol Clin. 1990 Oct;20(4):269-81.

PMID:
2290411
33.

[Clinico-developmental aspects in 44 cases of polymyositis/dermatomyositis].

Bravaccio F, Tirri R, Ammendola A, Picillo U, Cantore R, Trabucco M, Tirri G.

Acta Neurol (Napoli). 1989 Apr-Jun;11(2-3):102-16. Italian.

PMID:
2782112
34.

[Electromyographic studies in patients with progressive systemic sclerosis].

Bravaccio F, Tirri R, Ammendola A, Tirri G, Vatti M, Giordano M.

Acta Neurol (Napoli). 1986 Aug;8(4):398-403. Italian. No abstract available.

PMID:
3776720
36.

H-reflex behavior in glue (n-hexane) neuropathy.

Bravaccio F, Ammendola A, Barruffo L, Carlomagno S.

Clin Toxicol. 1981 Dec;18(12):1369-75.

PMID:
7333077
37.

[Congenital agenesis of the triangular muscle of the lip].

D'Avanzo M, D'Ascoli C, Ammendola A.

Pediatria (Napoli). 1981 Mar 31;89(1):99-108. Italian. No abstract available.

PMID:
7290830
38.

[Epilepsy and hypocalcemia. Further considerations on a case].

Ammendola A, Errico ET, Iannaccone S, Valerio P, Tata MR.

Acta Neurol (Napoli). 1981 Feb;3(1):11-6. Italian. No abstract available.

PMID:
7246287
39.

[Epilepsy and hypocalcemia. Further considerations on a case].

Ammendola A, Errico ET, Iannaccone S, Valerio P, Tata MR.

Acta Neurol Quad (Napoli). 1981;42:11-6. Italian. No abstract available.

PMID:
7270043
40.

Developmental changes of normal nerve conduction velocity in infancy.

Ammendola A, Federico A, Bravaccio F.

Acta Neurol (Napoli). 1980 Jun;2(3):155-65. No abstract available.

PMID:
7415881
41.

[Electrophysiological study of the masseter reflex in individuals suffering from maxillo-palpebral syncinesia of Marcus Gunn (author's transl)].

Sanna G, D'Esposito M, Ammendola A.

Rev Otoneuroophtalmol. 1979 Oct-Dec;51(5):461-6. French. No abstract available.

PMID:
542771
42.

[Roussy-Levi disease (Study of a familial nucleus)].

Paolozzi C, Ammendola A, Bravaccio F, Tata MR, Volpe E, De Angelis G.

Acta Neurol (Napoli). 1977 May-Jun;32(3):263-75. Italian. No abstract available.

PMID:
883520

Supplemental Content

Loading ...
Support Center